The mechanism of lipid raft mediating chemoresistance of cervical cancer

Saudi Medical Journal

Volumn 33, Issue 5, 2012, Pages 508-514

  Cheng, Yan Xiang ^a   Hu, Min ^a   Chen, Liao ^a   Huang, Jin Ling ^a   Xia, Liang Bin ^a   Li, Bin Shu ^a   Zhou, Li Mei ^a   Hong, Li ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOCYNIN; CISPLATIN; DICHLORODIHYDROFLUORESCEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; METHYL BETA CYCLODEXTRIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CELL COUNT; CELL SURVIVAL; CHINA; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; LIPID RAFT; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING;

ACETOPHENONES; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIPID REGULATING AGENTS; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 84861209508     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rahaman J, Steiner N, Hayes MP, Chuang L, Fishman D, Gretz Iii H. Chemotherapy for gynecologic cancers. Mt Sinai J Med 2009; 76: 577-588.
2. Lu ZH, Wright JD, Belt B, Cardiff RD, Arbeit JM. Hypoxiainducible factor-1 facilitates cervical cancer progression in human papillomavirus type 16 transgenic mice. Am J Pathol 2007; 171: 667-681.
3. O'Toole D, Couvelard A, Rebours V, Zappa M, Hentic O, Hammel P, et al. Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors. Endocr Relat Cancer 2010; 17: 847-856.
4. Yeung HY, Lai KP, Chan HY, Mak NK, Wagner GF, Wong CK. Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells. Endocrinology 2005; 146: 4951-4960.
5. Li PL, Zhang Y, Yi F. Lipid raft redox signaling platforms in endothelial dysfunction. Antioxid Redox Signal 2007; 9: 1457-1470.
6. Jin S, Zhang Y, Yi F, Li PL. Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol 2008; 28: 485-490.
7. Marin R, Marrero-Alonso J, Fernandez C, Cury D, Diaz M. Estrogen receptors in lipid raft signalling complexes for neuroprotection. Front Biosci (Elite Ed) 2012; 4: 1420-1433.
8. Burri P, Djonov V, Aebersold DM, Lindel K, Studer U, Altermatt HJ. Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56: 494-501.
9. Rankin EB, Giaccia AJ.The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008;15: 678-685.
10. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010; 29: 625-634.
11. Cheng YX, Pu DM, Liu R, Li T, Yin L, Ma D. Influence of hypoxia inducible factor-1alpha on cervical cancer cell line HeLa in vitro. Zhonghua Fu Chan Ke Za Zhi 2007; 42: 551-554.
12. Semenza GL. Regulation of oxygen homeostasis by hypoxiainducible factor 1. Physiology (Bethesda) 2009; 24: 97-106.
13. Li B, Xu H, Li Z, Yao M, Xie M, Shen H. Bypassing multi drug resistance in human breast cancer cells with lipid/polymer particle assemblies. Int J Nanomedicine 2012; 7: 187-197.
14. Wilson PM, Lenz HJ. Integrating biomarkers into clinical decision making for colorectal cancer. Clin Colorectal Cancer 2010; 9 (Suppl 1): S16-S27.
15. Prabhakar NR, Kumar GK, Nanduri J, Semenza GL. ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid Redox Signal 2007; 9: 1397-1403.
16. Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 2009; 11: 1289-1899.
17. Wu WS. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 2006; 25: 695-705.
18. Irwin DC, McCord JM, Nozik-Grayck E, Beckly G, Foreman B, Sullivan T, et al. A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak. Free Radic Biol Med 2009; 47: 55-61.
19. Biswas S, Gupta MK, Chattopadhyay D, Mukhopadhyay CK. Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase. Am J Physiol Heart Circ Physiol 2007; 292: 758-766.
20. Moon EJ, Sonveaux P, Porporato PE, Danhier P, Gallez B, Batinic-Haberle I, et al. NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment. Proc Natl Acad Sci U S A 2010; 107: 20477-20482.
21. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science 2010; 327: 46-50.
22. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245-313.
23. Jin S, Zhou F, Katirai F, Li PL. Lipid Raft Redox Signaling: Molecular Mechanisms in Health and Disease. Antioxid Redox Signal 2011; 15: 1043-1083.
24. Schmitz G, Grandl M. Role of redox regulation and lipid rafts in macrophages during Ox-LDL-mediated foam cell formation. Antioxid Redox Signal 2007; 9: 1499-1518